Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.435 USD | +0.62% | -2.79% | -26.73% |
Mar. 20 | HC Wainwright Adjusts Coherus BioSciences' Price Target to $11 From $13, Keeps Buy Rating | MT |
Mar. 14 | Coherus BioSciences Shares Fall After Workforce Reduction Plan; Q4 Loss | MT |
Financials (USD)
Sales 2024 * | 262M | Sales 2025 * | 357M | Capitalization | 273M |
---|---|---|---|---|---|
Net income 2024 * | -69M | Net income 2025 * | -20M | EV / Sales 2024 * | 2.07 x |
Net Debt 2024 * | 268M | Net Debt 2025 * | 286M | EV / Sales 2025 * | 1.56 x |
P/E ratio 2024 * |
-4.4
x | P/E ratio 2025 * |
-22.5
x | Employees | 306 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.95% |
Latest transcript on Coherus BioSciences, Inc.
1 day | +5.22% | ||
1 week | -2.42% | ||
Current month | +6.14% | ||
1 month | -7.63% | ||
3 months | -10.04% | ||
6 months | -39.04% | ||
Current year | -27.33% |
Managers | Title | Age | Since |
---|---|---|---|
Denny Lanfear
CEO | Chief Executive Officer | 68 | 10-08-31 |
Bryan Mcmichael
DFI | Director of Finance/CFO | 46 | 21-02-28 |
Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Stolper
BRD | Director/Board Member | 52 | 21-01-04 |
Mats Wahlström
BRD | Director/Board Member | 70 | 11-12-31 |
Ali Satvat
BRD | Director/Board Member | 46 | 14-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.436 | +0.66% | 1 011 128 |
24-03-27 | 2.42 | +5.22% | 2,583,955 |
24-03-26 | 2.3 | +0.88% | 4,936,909 |
24-03-25 | 2.28 | -2.15% | 1,921,134 |
24-03-22 | 2.33 | -7.17% | 2,085,061 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.33% | 273M | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.10% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |